Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era

BACKGROUND: Immuno-oncology (IO) agents and tyrosine kinase inhibitors (TKIs) have revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). Data on real-world usage and outcomes are limited. OBJECTIVE: To examine real-world treatment patterns and clinical outcomes for mRCC....

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Neil J., Sura, Sneha D., Shinde, Reshma, Shi, Junxin, Singhal, Puneet K., Robert, Nicholas J., Vogelzang, Nicholas J., Perini, Rodolfo F., Motzer, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Kidney Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974999/
https://www.ncbi.nlm.nih.gov/pubmed/36874600
http://dx.doi.org/10.1016/j.euros.2022.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974999/
https://www.ncbi.nlm.nih.gov/pubmed/36874600
http://dx.doi.org/10.1016/j.euros.2022.12.015

Ejemplares similares